The projected revenue growth of the global Non-Small Cell Lung Cancer (NSCLC) market is driven by various factors. By 2030, it is expected to reach USD 13.51 Billion, with a revenue CAGR of 6.8% during the forecast period.
https://www.reportsanddata.com..../report-detail/non-s
Like
Comment
Share
